Journal of the Pancreas is described as the most authenticated electronic journals on Autoimmune pancreatitis. Journal of the Pancreas (JOP) is a scholarly Open Access journal that has successfully published the most complete and reliable source of information covering the most advanced research findings about Autoimmune pancreatitis.
Autoimmune pancreatitis (AIP) is a newly discovered type of chronic pancreatitis that can be difficult to distinguish from pancreatic carcinoma. Autoimmune pancreatitis (AIP) is found to responds to treatment with corticosteroids, especially prednisone. Nowadays it is regarded as a form of hyper-IgG4 disease. There are two categories of AIP: Types 1 and Type 2 each with different clinical profiles. Type 1 AIP patients tended to be older and have a high relapse rate, but patients with Type 2 AIP do not experience relapse and tend to be younger. AIP does not affect long-term survival.
Journal of the Pancreas is published by OMICS Group, one of the reputed Open Access publishers in the world. OMICS Group International is the leading online open access publisher and scientific event organizer involved in publishing around 700+ peer-reviewed journals along with successful organization of 3000+ International Scientific Conferences annually across the globe.
Last date updated on June, 2014